JHESP Cilt 7, Sayı 1
Sayı 12
A Systematic Review of the Burden of Disease Studies on Diabetes - Selin Coşkun - Vahit Yiğit Tıklayınız.
The Right of International Students to Access Healthcare in Practice and Turkish Legal Legislation - Gurur Gülce Beşe - Fırat Semih Avşar Tıklayınız.
Pharmaceutical Market Access in Türkiye: Processes, Challenges, and Opportunities - Öznur Seyhun Tıklayınız.
Alzheimer's Disease: A New Paradigm, New Treatments, New Challenges, New Approaches - Lütfü Hanoğlu - Deniz Eruçar - Tehran Aliyeva - Beyza Tağraf Tıklayınız.
Dergimize Dergi Park üzerinden ulaşmak için Tıklayınız.
1Diabetes is a major cause of morbidity and premature mortality on a global scale, and its prevalence has been increasing in recent decades. The overall health impact of the disease is measured by disability-adjusted life years (DALYs), which is the sum of years of life lost due to disability (YLDs) and years of life lost due to premature death (YLLs). This systematic review was conducted to evaluate studies that estimated the burden of diabetes at the global, national, or regional level, and to identify and review the epidemiological metrics (DALYs, YLDs, YLLs, incidence, prevalence, and mortality) and the methods used to determine the burden of disease. A comprehensive search strategy was employed to identify eligible studies published between January 1, 2000, and December 31, 2024, in MEDLINE, Scopus, ScienceDirect, BioMed Central and CINAHL databases. The study was conducted in accordance with the PRISMA 2020 guidelines. Studies that utilized DALYs or their subsets (YLDs/YLLs) as measures of the health impact of diabetes and that were published in English were included in the review. Following a thorough evaluation of the relevant literature, a total of 16 studies out of 1,307 were deemed to be eligible for review. This research reveals a lack of harmonization of epidemiological data and methods that hinder the capacity for meaningful comparisons across studies of the burden of diabetes. The findings outlined in this study provide a comprehensive framework for the diversification of diabetes burden of disease studies across different countries and regions, with a particular focus on the global level.